J8X-11592-96014
4 vaccinations
5 coded responses
38 check-ins
3 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 926 / CA
- Registered
- 2020-12-29
- Relationship
- Self
- Race
- Multiracial
- Ethnicity
- Not Hispanic or Latino
Registered dependents
9JR-18432-96688
Child or adolescent in my care · Male · 2022-07-13
UFN-15625-09864
Child or adolescent in my care · Male · 2022-07-13
Timeline
-
2020-12-29
Registered in v-safe
-
2020-12-29
Dose 1 — Pfizer-BioNTech
- 2020-12-29
- 2020-12-30
- 2020-12-31
- 2021-01-01
- 2021-01-02
- 2021-01-03
- 2021-01-04
- 2021-01-05
- 2021-01-12
-
2021-01-19
Dose 2 — Pfizer-BioNTech
- 2021-01-19
-
2021-01-20
Health check-in — days 1–6 daily, dose 2Feeling: Poor · Site: Pain · Fever · Chills, Headache, Muscle or body aches, Fatigue or tiredness · Be unable to workAdult check-in
- 2021-01-21
- 2021-01-23
- 2021-01-24
- 2021-01-25
- 2021-01-26
- 2021-02-04
- 2021-02-09
-
2021-02-16
Survey response — day 28, dose 2MedDRA: Fatigue, Feeling abnormal, Nasopharyngitis, Oropharyngeal pain — Feeling: FairFree text: Cold symptoms (fatigue, slight sore throat, brain fog) but son is also sick from school so likely not relatedMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-02-23
- 2021-03-02
- 2021-04-20
- 2021-07-20
-
2021-10-01
Dose 3 — Pfizer-BioNTech
-
2021-10-01
Health check-in — day 0, dose 3Feeling: Fair · Site: Pain · Headache, Muscle or body aches, Fatigue or tirednessAdult check-in
-
2021-10-02
Health check-in — days 1–6 daily, dose 3Feeling: Good · Site: Pain · Headache, Muscle or body aches, Fatigue or tirednessAdult check-in
-
2021-10-03
Health check-in — days 1–6 daily, dose 3Feeling: Good · Fatigue or tiredness, NauseaAdult check-in
- 2021-10-04
-
2021-10-05
Survey response — days 1–6 daily, dose 3MedDRA: Injection site erythema — Feeling: Good · Site: Redness, SwellingFree text: I previously had redness at injection site on other days but I hadn't noticedMedDRA releases: 2024-11 · check-in free text available
- 2021-10-08
- 2021-10-15
- 2021-10-22
- 2021-10-29
- 2021-11-05
- 2021-11-12
-
2021-12-31
Survey response — 3 months, dose 3MedDRA: Oropharyngeal pain, Productive cough, Rhinorrhoea — Feeling: Fair · Be unable to do your normal daily activitiesFree text: Runny nose, productive cough, sore throat 3+ days,MedDRA releases: 2024-11 · check-in free text available
- 2022-04-01
-
2022-12-21
Dose 4 — Moderna
-
2023-03-22
Survey response — 3 months, dose 4MedDRA: COVID-19, Pregnancy — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationMedDRA releases: 2024-11
-
2023-03-22
Report sent to call center — 3 months, dose 4Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prTelehealth, virtual health, or email health consultation · 1 call case(s)
- 2023-03-23
-
2023-03-23
Callback requested for04:00PM ET
-
2023-03-23
Call successfulCompleted over the phone
-
2023-06-21
Survey response — 6 months, dose 4MedDRA: Headache, Oropharyngeal pain — Feeling: FairMedDRA releases: 2024-11
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2020-12-29 | Pfizer-BioNTech | |
| 2 | 2021-01-19 | Pfizer-BioNTech | |
| 3 | 2021-10-01 | Pfizer-BioNTech | No |
| 4 | 2022-12-21 | Moderna | No |
Call center
1 call center case
1 successful
VAERS report filed, before or during a call: 1
Free text
Release 4 — day 28, dose 2
Symptoms: Cold symptoms (fatigue, slight sore throat, brain fog) but son is also sick from school so likely not related
Release 10 — days 1–6 daily, dose 3
Systemic reaction (other): I previously had redness at injection site on other days but I hadn't noticed
Release 10 — 3 months, dose 3
Symptoms: Runny nose, productive cough, sore throat 3+ days,
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | COVID-19 | · | · | ✓ |
| SD | Fatigue | ✓ | ✓ | ✓ |
| SD | Feeling abnormal | ✓ | ✓ | ✓ |
| SD | Headache | · | · | ✓ |
| SD | Nasopharyngitis | ✓ | ✓ | ✓ |
| SD | Oropharyngeal pain | ✓ | ✓ | ✓ |
| SD | Pregnancy | · | · | ✓ |
| SD | Productive cough | · | · | ✓ |
| SD | Rhinorrhoea | · | · | ✓ |
| SRO | Injection site erythema | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release